Your browser doesn't support javascript.
loading
Assessment and management of newly diagnosed classical Hodgkin lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.
Cochrane, Tara; Campbell, Belinda A; Gangatharan, Shane A; Latimer, Maya; Khor, Richard; Christie, David R H; Gilbertson, Michael; Ratnasingam, Sumita; Palfreyman, Emma; Lee, Hui-Peng; Trotman, Judith; Hertzberg, Mark; Dickinson, Michael.
Afiliación
  • Cochrane T; Department of Haematology, Gold Coast University Hospital, Gold Coast, Queensland, Australia.
  • Campbell BA; School of Medicine, Griffiths University, Gold Coast, Queensland, Australia.
  • Gangatharan SA; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Latimer M; Department of Clinical Pathology, University of Melbourne, Parkville, Victoria, Australia.
  • Khor R; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
  • Christie DRH; Fiona Stanley Hospital, Perth, Western Australia, Australia.
  • Gilbertson M; University of Western Australia, Perth, Western Australia, Australia.
  • Ratnasingam S; ACT Pathology and Canberra Hospital, Canberra, Australian Capital Territory, Australia.
  • Palfreyman E; Austin Hospital, Melbourne, Victoria, Australia.
  • Lee HP; Genesiscare, Gold Coast, Queensland, Australia.
  • Trotman J; Bond University, Gold Coast, Queensland, Australia.
  • Hertzberg M; Monash Health, Melbourne, Victoria, Australia.
  • Dickinson M; School of Clinical Sciences, Monash University, Melbourne, Victoria, Australia.
Intern Med J ; 51(12): 2119-2128, 2021 Dec.
Article en En | MEDLINE | ID: mdl-34505342
The management of Hodgkin lymphoma (HL) has undergone significant changes in recent years. Due to the predilection of HL to affect younger patients, balancing cure and treatment-related morbidity is a constant source of concern for physicians and patients alike. Positron emission tomography adapted therapy has been developed for both early and advanced stage HL to try and improve the outcome of treatment, while minimising toxicities. The aim of this review is to digest the plethora of studies recently conducted and provide some clear, evidence-based practice statements to simplify the management of HL.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Intern Med J Asunto de la revista: MEDICINA INTERNA Año: 2021 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Australia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Intern Med J Asunto de la revista: MEDICINA INTERNA Año: 2021 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Australia